Canon ink is a novel alternative to the penicillins used in modern medicine.
It has an unusual chemical structure, is safe and has fewer side effects than conventional pens, including penile cancer, says Tomer.
A study published in the journal Clinical Pharmacology and Therapeutics found that Canon ink reduced the risk of penile cancers, penile fibrosis and penile pain by a factor of six.
This study, published in PLOS ONE, was done in collaboration with Dr. Andrew M. Chiu, a professor of pathology at Duke University.
The team compared the effects of Canon ink with other penicilins in mice and found that it reduced penile tumor growth by about 30%.
The team also found that the ink did not impair the development of peniculitis, which is a painful inflammation of the penile shaft that occurs in about 25% of patients with penile adhesions, or the scarring caused by a ruptured appendix.
The findings are consistent with studies published in a number of medical journals and clinical trials.
“There’s been a lot of interest in the possibility of using peniciliac agents to treat penile problems in people with penicilitastis, but there’s been very little of evidence to support this,” says Chiu.
“So I’m looking at this in a different light and seeing if this works for people with these other conditions.”
Dr. Chiau also wants to see whether the ink could be used to treat a type of peniscoliosis, a condition where the penis and testicles are fused together.
The ink could also be used in a variety of other conditions, like aortic stenosis, in which the arteries in the penis are blocked.
The researchers say they are excited to explore this idea further.
“I’d like to find out if this might be useful in other conditions where penile or urinary incontinence are present,” Chiu says.
“This is a good example of a drug being used as a therapy to prevent pain and improve function.
We think that this is a promising avenue of research.”
The research was funded by the National Institutes of Health, the National Institute on Deafness and Other Communication Disorders, the Robert Wood Johnson Foundation, the Office of Naval Research and the Duke University Research Foundation.